RESUMEN
Neurocysticercosis, an infection of the central nervous system with the larval stage of the cestode Taenia solium, is common in developing countries but its occurrence and management in allogeneic hematopoietic stem cell transplantation (HSCT) has not been reported previously, to our knowledge. We report the case of an immigrant female patient who underwent a matched-related allogeneic HSCT for acute lymphoblastic leukemia and was incidentally found to have a solitary viable neurocysticercosis lesion. However, despite severe immunosuppression, the size of the cyst did not increase. More importantly, restoration of the immune system did not induce significant inflammation or seizures. Subsequent follow-up demonstrated complete resolution of the neurocysticercosis lesion. Thus, in the setting of HSCT, an asymptomatic patient with a single neurocysticercosis lesion was successfully managed without the use of anthelmintics, steroids, or anti-epileptics.
Asunto(s)
Trasplante de Células Madre Hematopoyéticas/efectos adversos , Neurocisticercosis/complicaciones , Leucemia-Linfoma Linfoblástico de Células Precursoras/complicaciones , Adulto , Quistes , Femenino , Humanos , Terapia de Inmunosupresión , Neurocisticercosis/terapia , Leucemia-Linfoma Linfoblástico de Células Precursoras/cirugía , Trasplante HomólogoRESUMEN
Neurocysticercosis resulting from Taenia solium infections is a major cause of adult-acquired seizures worldwide. Disease is caused by larval cysts, and treatment consists of the anthelmintic drugs albendazole or praziquantel. There are no standard methods to assess drug activity to T. solium cysts in vitro. Morphological, functional, and biochemical changes that might reflect damaging (inhibiting, cytotoxic) drug effects were analyzed after exposure of cysts to albendazole sulfoxide (ABZ-SO), the major active metabolite of the drug in vivo, praziquantel (PZQ), or combinations of both. PZQ exposure led to a decrease in cyst size and inhibition of evagination, whereas ABZ-SO exposure resulted in minimal changes. Alkaline phosphatase (AP) is normally secreted by cysts, and both drugs inhibited AP secretion at concentrations of 5 and 50 ng/ml for PZQ and ABZ-SO, respectively. Some combinations of both drugs resulted in additive and/or synergistic activities. Parasite-specific antigen, detected in the cerebrospinal fluid and blood of infected patients, is also normally secreted by T. solium cysts. Antigen secretion was similarly inhibited by ABZ-SO and PZQ and a combination of both drugs, suggesting that inhibition of secretion is a common downstream consequence of the activities of both drugs. These studies establish quantitative methods to measure in vitro anthelmintic activity and suggest combination therapy with ABZ-SO and PZQ may have clinical benefit.
Asunto(s)
Albendazol/farmacología , Antihelmínticos/farmacología , Praziquantel/farmacología , Taenia solium/efectos de los fármacos , Animales , Ensayo de Inmunoadsorción Enzimática , Taenia solium/metabolismoRESUMEN
Adenosine diphosphate (ADP) initiates and maintains sustained aggregation of platelets through simultaneous activation of both the Gq-coupled P2Y1 receptor and the Gi-coupled P2Y12 receptor. We recently described the synthesis and P2Y1 receptor-specific agonist activity of (N)-methanocarba-2MeSADP (MRS2365). Consequences of selective activation of the P2Y1 receptor by MRS2365 have been further examined in human platelets. Whereas MRS2365 alone only induced shape change, addition of MRS2365 following epinephrine treatment, which activates the Gi/z-linked, alpha2A-adrenergic receptor, resulted in sustained aggregation that was indistinguishable from that observed with ADP. Conversely, the platelet shape change promoted by ADP in the presence of the GPIIb/IIIa antagonist eptifibatide was similar to that promoted by MRS2365. Preaddition of the high affinity P2Y1 receptor antagonist MRS2500 inhibited the effect of MRS2365, whereas addition of MRS2500 subsequent to MRS2365 reversed the MRS2365-induced shape change. Preactivation of the P2Y1 receptor with MRS2365 for 2 min resulted in marked loss of capacity of ADP to induce aggregation as evidenced by a greater than 20-fold rightward shift in the concentration effect curve of ADP. This inhibitory effect of P2Y1 receptor activation was dependent on the concentration of MRS2365 (EC50 = 34 nm). The inhibitory effect of preincubation with MRS2365 was circumvented by activation of the Gq-coupled 5-HT2A receptor suggesting that MRS2365 induces loss of the ADP response as a consequence of desensitization of the Gq-coupled P2Y1 receptor. The time course of MRS2365-induced loss of aggregation response to epinephrine was similar to that observed with ADP. These results further demonstrate the P2Y1 receptor selectivity of MRS2365 and illustrate the occurrence of agonist-induced desensitization of the P2Y1 receptor of human platelets studied in the absence of P2Y12 receptor activation .
Asunto(s)
Adenosina Difosfato/análogos & derivados , Plaquetas/metabolismo , Agonistas del Receptor Purinérgico P2 , Receptores Purinérgicos P2/metabolismo , Adenosina Difosfato/química , Adenosina Difosfato/farmacología , Plaquetas/ultraestructura , Epinefrina/farmacología , Humanos , Microscopía Electrónica de Rastreo , Agregación Plaquetaria/efectos de los fármacos , Receptores Purinérgicos P2Y1 , Receptores Purinérgicos P2Y12RESUMEN
In this communication the authors analyzed the pattern of expression of IFN-gamma as a surrogate type 1 response in different clinical forms of schistosomiasis in response to stimulation involving T-cell dependent and T-cell independent pathways, to investigate which pathways were functional in human schistosomiasis, and to further characterize the nature of Th1 response impairment in this parasitic disease.
Asunto(s)
Antígenos CD40/fisiología , Ligando de CD40/fisiología , Interferón gamma/metabolismo , Esquistosomiasis mansoni/metabolismo , Antígenos CD40/metabolismo , Ligando de CD40/metabolismo , Humanos , Inmunidad Celular , Esquistosomiasis mansoni/inmunología , Staphylococcus aureus/inmunología , Linfocitos T Colaboradores-Inductores/metabolismoRESUMEN
Ebola virus infection of humans is associated with high levels of circulating inflammatory chemokines and cytokines. We demonstrate that direct infection of human PBMC results in the induction of MCP-1, MIP-1alpha, RANTES, and TNF-alpha as early as 24 h p.i. in response to live virus. Monocyte-derived macrophages infected with live Ebola-virus secreted MIP-1alpha and TNF-alpha specifically while RANTES and MCP-1 were secreted by with both live or inactivated virus stimulation and do not require viral replication. Type I interferons (IFN-alpha and -beta), IL-1beta and IL-10, were not induced by Ebola virus. Furthermore, live virus infection of both PBMCs and monocytes-derived macrophages inhibited IFN-alpha induced by double-stranded RNA in vitro. These data provide the first direct evidence of a role for macrophages in the pathogenesis to Ebola virus and suggest that Ebola virus can inhibit cellular antiviral mechanisms mediated by type I interferons.
Asunto(s)
Fiebre Hemorrágica Ebola/sangre , Interferón-alfa/sangre , Proteínas Inflamatorias de Macrófagos/sangre , Macrófagos/virología , Monocitos/virología , Poli I-C/farmacología , Factor de Necrosis Tumoral alfa/metabolismo , Células Cultivadas , Quimiocina CCL2/sangre , Quimiocina CCL3 , Quimiocina CCL4 , Quimiocina CCL5/sangre , Ebolavirus , Ensayo de Inmunoadsorción Enzimática , Humanos , Interferón beta/sangre , Interleucina-1/sangre , Interleucina-10/sangre , Macrófagos/efectos de los fármacos , Macrófagos/metabolismo , Monocitos/efectos de los fármacos , Monocitos/metabolismo , ARN Bicatenario/farmacologíaRESUMEN
To investigate the role of inflammatory mediators in the pathogenesis of Lassa fever, the levels of a number of pro- and anti-inflammatory cytokines and chemokines in serum samples collected from hospitalized patients with fatal and nonfatal acute Lassa fever were compared with those from 2 control groups: patients with other febrile illnesses and uninfected individuals. Serum interleukin (IL)-8 and interferon (IFN)-inducible protein (IP)-10 levels were significantly higher in patients with acute nonfatal Lassa fever than in control subjects. In striking contrast, levels of these chemokines were low or undetectable in patients with fatal Lassa fever. IFN-gamma, IL-12, IL-6, and RANTES levels were elevated in all the febrile study groups. Tumor necrosis factor-alpha levels were not elevated in patients with fatal or nonfatal Lassa fever. These data indicate that acute nonfatal Lassa fever is associated with high levels of circulating IL-8 and IP-10 and that low levels or absence of these mediators correlates with a poor outcome.
Asunto(s)
Quimiocinas CXC/sangre , Interleucina-8/sangre , Fiebre de Lassa/inmunología , Fiebre de Lassa/mortalidad , Enfermedad Aguda , Estudios de Casos y Controles , Quimiocina CCL5/sangre , Quimiocina CCL5/inmunología , Quimiocina CXCL10 , Quimiocinas CXC/inmunología , Ensayo de Inmunoadsorción Enzimática , Hospitalización , Humanos , Interferón gamma/sangre , Interferón gamma/inmunología , Interleucina-12/sangre , Interleucina-12/inmunología , Interleucina-6/sangre , Interleucina-6/inmunología , Interleucina-8/inmunología , CinéticaRESUMEN
Ebola hemorrhagic fever is a severe, usually fatal illness caused by Ebola virus, a member of the filovirus family. The use of nonhomologous immune serum in animal studies and blood from survivors in two anecdotal reports of Ebola hemorrhagic fever in humans has shown promise, but the efficacy of these treatments has not been demonstrated definitively. We have evaluated the protective efficacy of polyclonal immune serum in a mouse model of Ebola virus infection. Our results demonstrate that mice infected subcutaneously with live Ebola virus survive infection and generate high levels of anti-Ebola virus immunoglobulin G (IgG). Passive transfer of immune serum from these mice before challenge protected upto 100% of naive mice against lethal Ebola virus infection. Protection correlated with the level of anti-Ebola virus IgG titers, and passive treatment with high-titer antiserum was associated with a delay in the peak of viral replication. Transfer of immune serum to SCID mice resulted in 100% survival after lethal challenge with Ebola virus, indicating that antibodies alone can protect from lethal disease. Thus antibodies suppress or delay viral growth, provide protection against lethal Ebola virus infection, and may not require participation of other immune components for protection.
Asunto(s)
Anticuerpos Antivirales/inmunología , Fiebre Hemorrágica Ebola/prevención & control , Inmunización Pasiva , Replicación Viral/inmunología , Animales , Chlorocebus aethiops , Modelos Animales de Enfermedad , Ebolavirus/inmunología , Ebolavirus/fisiología , Femenino , Fiebre Hemorrágica Ebola/virología , Humanos , Sueros Inmunes/inmunología , Inmunización Pasiva/métodos , Inmunocompetencia , Inmunoglobulina G/metabolismo , Inyecciones Subcutáneas , Masculino , Ratones , Ratones Endogámicos BALB C , Ratones SCID , Células VeroRESUMEN
Filamentous fungi are a large group of diverse and economically important microorganisms. Large-scale gene disruption strategies developed in budding yeast are not applicable to these organisms because of their larger genomes and lower rate of targeted integration (TI) during transformation. We developed transposon-arrayed gene knockouts (TAGKO) to discover genes and simultaneously create gene disruption cassettes for subsequent transformation and mutant analysis. Transposons carrying a bacterial and fungal drug resistance marker are used to mutagenize individual cosmids or entire libraries in vitro. Cosmids are annotated by DNA sequence analysis at the transposon insertion sites, and cosmid inserts are liberated to direct insertional mutagenesis events in the genome. Based on saturation analysis of a cosmid insert and insertions in a fungal cosmid library, we show that TAGKO can be used to rapidly identify and mutate genes. We further show that insertions can create alterations in gene expression, and we have used this approach to investigate an amino acid oxidation pathway in two important fungal phytopathogens.
Asunto(s)
Ascomicetos/genética , Genes Fúngicos/genética , Madurella/genética , Alelos , Clonación Molecular , Cósmidos/genética , Productos Agrícolas/microbiología , Elementos Transponibles de ADN/genética , Proteínas Fúngicas/genética , Proteínas Fúngicas/fisiología , Eliminación de Gen , Regulación Fúngica de la Expresión Génica , Genes Fúngicos/fisiología , Biblioteca Genómica , Mutagénesis Insercional/genética , Mutagénesis Sitio-Dirigida/genética , Fenotipo , Reproducibilidad de los Resultados , Análisis de Secuencia de ADN , Transformación GenéticaRESUMEN
The protozoan parasite Giardia lamblia is a major cause of waterborne enteric disease worldwide. Lectins are proteins that bind to carbohydrate (sugar) moieties. Potential targets for lectins are found on the surface of most single-celled organisms. Modest concentrations of wheat germ agglutinin (WGA) have been shown to inhibit G. lamblia excystation and trophozoite growth in vitro and can reduce cyst passage in mice infected with the closely related protozoan parasite, G. muris. Commercial preparations of wheat germ (WG) contain 13-53 microg of WGA per gram. We performed a double-masked, placebo-controlled study of dietary supplementation with WG in 63 subjects with giardiasis in Montreal and Lima (25 asymptomatic patients passing cysts; 38 patients with symptoms). Asymptomatic subjects received WG (2 g, 3 times a day) or placebo (cornstarch, 2 g, 3 times a day) for 10 days, followed by metronidazole (250 mg 3 times a day) for 7 days. Symptomatic subjects received metronidazole (250 mg 3 times a day) plus either WG or placebo for 7 days. Stool specimens were collected every day (Montreal) or every other day (Lima) for 10 days and on Day 35 for microscopic examination and coproantigen determination. Subjects kept a diary of symptoms for 10 days after recruitment. In asymptomatic subjects, both cyst passage and coproantigen levels were reduced by approximately 50% in those taking WG compared with the placebo group (P < 0.01 and P = 0.06, respectively). In symptomatic subjects, cyst passage and coproantigen levels fell precipitously in response to metronidazole therapy, and there were no clinically important differences between those receiving supplemental WG or placebo. However, symptoms appear to have resolved more rapidly in the subjects taking WG in addition to metronidazole. The WG supplement was well tolerated in both symptomatic and asymptomatic subjects. These data suggest that components of WG, possibly WGA, either alone or in combination with antiprotozoal agents, can influence the course of human giardiasis.
Asunto(s)
Antitricomonas/uso terapéutico , Suplementos Dietéticos , Giardiasis/tratamiento farmacológico , Fitoterapia , Triticum , Aglutininas del Germen de Trigo/uso terapéutico , Adulto , Animales , Antitricomonas/administración & dosificación , Método Doble Ciego , Heces/parasitología , Femenino , Giardia lamblia/aislamiento & purificación , Humanos , Masculino , Metronidazol/administración & dosificación , Metronidazol/uso terapéutico , Perú , Lectinas de Plantas , Quebec , Resultado del Tratamiento , Aglutininas del Germen de Trigo/administración & dosificaciónRESUMEN
Physicochemical techniques such as gamma-irradiation, membrane disruption by detergents like sodium dodecyl sulfate (SDS), and fixation with formaldehyde or paraformaldehyde are routinely used to inactivate biological specimens from patients and animals infected with Filoviruses and Arena viruses that must be studied in BSL 4 facilities. The effects of these inactivation techniques on the levels of immunologically active proteins like cytokines and chemokines are not known. Therefore, we investigated the effect of several decontamination techniques on the immunoreactivity and bioactivity of the inflammatory cytokines IL-1beta, IL-6, TNF-alpha, IL-12, and IFN-gamma, the anti-inflammatory cytokine IL-10, and the chemokine IL-8 in biological specimens. SDS (96%-100% reduction), paraformaldehyde treatment (11%-100% reduction), and heat denaturation (75%-100% reduction) were found to decrease markedly the levels of all cytokines and chemokines as measured by enzyme-linked immunosorbent assays. In contrast, gamma-irradiation was found to have little or no effect on the immunoreactivity of these cytokines/chemokines and on the biological activity of tumor necrosis factor (TNF) alpha. Our data suggest that, of the agents tested, gamma-irradiation is the preferred technique for inactivation of biological specimens containing viral agents that require the use of BSL 4 for immunological studies.
Asunto(s)
Citocinas/análisis , Leucocitos Mononucleares/inmunología , Antiinfecciosos Locales/farmacología , Línea Celular , Citocinas/efectos de los fármacos , Citocinas/efectos de la radiación , Formaldehído/farmacología , Rayos gamma , Calor , Humanos , Leucocitos Mononucleares/efectos de los fármacos , Leucocitos Mononucleares/virología , Lipopolisacáridos/farmacología , Fitohemaglutininas/farmacología , Polímeros/farmacología , Proteínas Recombinantes/análisis , Proteínas Recombinantes/efectos de los fármacos , Proteínas Recombinantes/efectos de la radiación , Dodecil Sulfato de Sodio/farmacología , Tensoactivos/farmacologíaRESUMEN
Localization of Ste5 to GP at the plasma membrane is essential for transmission of the pheromone signal to associated MAP kinase cascade enzymes. Here, we show that this crucial localization requires prior shuttling of Ste5 through the nucleus. Ste5 shuttles through the nucleus constitutively during vegetative growth. Pheromone enhances nuclear export of Ste5, and this pool translocates vectorially to the cell periphery. Remarkably, Ste5 that cannot transit the nucleus is unable to localize at the periphery and activate the pathway, while Ste5 with enhanced transit through the nucleus has enhanced ability to localize to the periphery and activate the pathway. This novel regulatory scheme may ensure that cytoplasmic Ste5 does not activate downstream kinases in the absence of pheromone and could be applicable to other membrane-recruited signaling proteins.
Asunto(s)
Proteínas Adaptadoras Transductoras de Señales , Proteínas Quinasas Dependientes de Calcio-Calmodulina/fisiología , Proteínas Portadoras , Membrana Celular/metabolismo , Núcleo Celular/metabolismo , Proteínas Fúngicas/metabolismo , Péptidos/fisiología , Receptores de Péptidos/fisiología , Proteínas de Saccharomyces cerevisiae , Saccharomyces cerevisiae/fisiología , Transducción de Señal/fisiología , Factores de Transcripción , Transporte Biológico , Técnica del Anticuerpo Fluorescente Indirecta , Proteínas Fúngicas/genética , Proteínas de Unión al GTP/fisiología , Regulación Fúngica de la Expresión Génica , Factor de Apareamiento , Proteínas de la Membrana/metabolismo , Receptores del Factor de Conjugación , Saccharomyces cerevisiae/citología , Saccharomyces cerevisiae/genética , Saccharomyces cerevisiae/metabolismoRESUMEN
The contribution of interleukin (IL)-10 and interferon (IFN)-gamma to the regulation of type 1 and type 2 cytokine responses was investigated in Brazilians with different clinical forms of schistosomiasis mansoni. Cells from members of a family with acute intestinal schistosomiasis responded to schistosomal soluble egg antigen (SEA) or soluble adult worm antigen preparation (SWAP) with greater amounts of IFN-gamma than did cells from several patients with chronic intestinal schistosomiasis; IL-10 levels were similar. Neutralization of IL-10 had no effect on the SEA-specific IFN-gamma response in patients with acute infection, whereas SWAP-induced IFN-gamma was increased in both groups. Anti-IL-10 also up-regulated SEA-specific IFN-gamma protein and mRNA responses in most splenocyte cultures from hepatosplenic schistosomiasis patients but had no effect on antigen-specific IL-4 or IL-5 production. Neutralization of IFN-gamma resulted in a comparable increase in SWAP-specific IL-10 and IL-5, while IL-4 was not affected. These studies demonstrate that early disease in schistosomiasis is associated with a significant IFN-gamma response and that IL-10 contributes to the suppression of that response during both early and chronic infection.
Asunto(s)
Antígenos Helmínticos/inmunología , Citocinas/biosíntesis , Leucocitos Mononucleares/inmunología , Esquistosomiasis mansoni/inmunología , Bazo/inmunología , Enfermedad Aguda , Adolescente , Adulto , Enfermedad Crónica , Femenino , Hepatomegalia , Humanos , Interferón gamma/biosíntesis , Interferón gamma/genética , Interleucina-10/biosíntesis , Interleucina-12/farmacología , Masculino , Persona de Mediana Edad , ARN Mensajero/aislamiento & purificación , Bazo/citología , EsplenomegaliaRESUMEN
The MAP kinase Fus3 regulates many different signal transduction outputs that govern the ability of Saccharomyces cerevisiae haploid cells to mate. Here we characterize Fus3 localization and association with other proteins. By indirect immunofluorescence, Fus3 localizes in punctate spots throughout the cytoplasm and nucleus, with slightly enhanced nuclear localization after pheromone stimulation. This broad distribution is consistent with the critical role Fus3 plays in mating and contrasts that of Kss1, which concentrates in the nucleus and is not required for mating. The majority of Fus3 is soluble and not bound to any one protein; however, a fraction is stably bound to two proteins of approximately 60 and approximately 70 kDa. Based on fractionation and gradient density centrifugation properties, Fus3 exists in a number of complexes, with its activity critically dependent upon association with other proteins. In the presence of alpha factor, nearly all of the active Fus3 localizes in complexes of varying size and specific activity, whereas monomeric Fus3 has little activity. Fus3 has highest specific activity within a 350- to 500-kDa complex previously shown to contain Ste5, Ste11, and Ste7. Ste5 is required for Fus3 to exist in this complex. Upon alpha factor withdrawal, a pool of Fus3 retains activity for more than one cell cycle. Collectively, these results support Ste5's role as a tether and suggest that association of Fus3 in complexes in the presence of pheromone may prevent inactivation in addition to enhancing activation.
Asunto(s)
Proteínas Adaptadoras Transductoras de Señales , Proteínas Portadoras , Proteínas Fúngicas/aislamiento & purificación , Proteínas Fúngicas/metabolismo , Proteínas Quinasas Activadas por Mitógenos , Proteínas de Saccharomyces cerevisiae , Saccharomyces cerevisiae/metabolismo , Proteínas de Schizosaccharomyces pombe , Factores de Transcripción , Núcleo Celular/metabolismo , Centrifugación/métodos , Citoplasma/metabolismo , Técnica del Anticuerpo Fluorescente Indirecta , Proteínas Fúngicas/efectos de los fármacos , Glicerol , Isoenzimas/metabolismo , Quinasas Quinasa Quinasa PAM/metabolismo , Factor de Apareamiento , Quinasas de Proteína Quinasa Activadas por Mitógenos , Peso Molecular , Péptidos/metabolismo , Péptidos/farmacología , Proteínas Quinasas/metabolismo , Saccharomyces cerevisiae/efectos de los fármacosRESUMEN
BACKGROUND: In the budding yeast Saccharomyces cerevisiae, the pheromones that induce haploid cells of opposite cell types to mate activate the Gbeta and Ggamma subunits of a heterotrimeric G protein. These subunits signal through the PAK kinase Ste20 to activate a mitogen-activated protein (MAP) kinase cascade comprising the MEKK Ste11, the MEK Ste7 and two MAP kinases, Fus3 and Kss1. The pathway requires Ste5, a scaffold protein that tethers the MAP kinase cascade enzymes into a high molecular weight complex. Ste5 is thought to associate with Gbeta in a pheromone-independent manner, but it is not known if this interaction affects signaling. RESULTS: A ste5C180A mutant - which expresses Ste5 disrupted in the LIM domain, a putative metal-binding motif that has been proposed to be essential for Ste5 oligomerization - could not transmit the pheromone signal from Gbeta through Ste20 to Ste11. The Ste5C180A protein was impaired in binding Gbeta, although it could oligomerize, bind Ste11, Ste7 and Fus3, facilitate the basal activation of Ste11, and relay the Ste11 signal to MAP kinases. Ste5 bound to Gbeta in a pheromone-dependent manner and preferentially associated with a phosphorylated form of Gbeta in wild-type and ste20Delta, but not in ste5C180A, strains. CONCLUSIONS: Pheromone induces binding of Gbeta to Ste5 through its LIM domain. This binding is essential for activation of Ste11 and is distinct from the ability of Ste5 to oligomerize or to serve as a scaffold and relay the signal from Ste11 to the MAP kinases. Pheromone also induces Ste5-dependent phosphorylation of Gbeta.
Asunto(s)
Proteínas Adaptadoras Transductoras de Señales , Proteínas Quinasas Dependientes de Calcio-Calmodulina/metabolismo , Proteínas Portadoras , Proteínas Fúngicas/metabolismo , Proteínas de Unión al GTP/metabolismo , Quinasas Quinasa Quinasa PAM/metabolismo , Proteínas Quinasas Activadas por Mitógenos , Proteínas de Saccharomyces cerevisiae , Proteínas de Schizosaccharomyces pombe , Factores de Transcripción , Alanina/genética , Alanina/metabolismo , Sitios de Unión , Activación Enzimática , Proteínas Fúngicas/genética , Quinasas de Proteína Quinasa Activadas por Mitógenos , Fenotipo , Mutación Puntual , Unión Proteica , Proteínas Quinasas/metabolismo , Saccharomyces cerevisiae , Transducción de SeñalRESUMEN
We investigated the mechanisms by which interleukin-10 (IL-10) regulates antigen-specific hyporesponsiveness in asymptomatic microfilaremic (MF) individuals. Peripheral blood mononuclear cells from MF individuals (n = 11) were stimulated in vitro with Brugia malayi antigen (BMA) or mycobacterial purified protein derivative (PPD) in the presence of neutralizing anti-IL-10 or isotype control monoclonal antibodies. As expected, BMA stimulated little or no gamma interferon (IFN-gamma) secretion in MF individuals, whereas PPD stimulated IFN-gamma in all but one. Neutralization of endogenous BMA-driven IL-10 secretion led to augmentation of IFN-gamma in seven of nine MF individuals (1.5- to 10-fold) and did so in a BMA-specific manner (PPD-driven IFN-gamma was augmented in only two of eight MF individuals and only 1.5- to 2-fold), indicating that IL-10 downregulates type 1 responses in these individuals. Type 2 responses (IL-5 secretion) were unaffected by the IL-10 blockade. To assess whether IL-12 could reverse the type 1 downregulation observed, the effect of recombinant human IL-12 (rhIL-12) on BMA-driven IL-5 and IFN-gamma production was also evaluated. rhIL-12 augmented both BMA- and PPD-driven IFN-gamma production 5- to 10-fold in six of nine MF individuals. These data demonstrate that IL-10 downregulates BMA-driven type 1 responses and that IL-12 can overcome downregulation of Th1 responses associated with MF but does so in a non-antigen-specific manner.
Asunto(s)
Antígenos Helmínticos/inmunología , Brugia Malayi/inmunología , Filariasis Linfática/inmunología , Interleucina-10/inmunología , Interleucina-12/inmunología , Adolescente , Adulto , Animales , Anticuerpos Bloqueadores/inmunología , Anticuerpos Monoclonales/inmunología , División Celular , Regulación hacia Abajo , Ensayo de Inmunoadsorción Enzimática , Femenino , Humanos , Interferón gamma/biosíntesis , Interleucina-12/genética , Interleucina-5/inmunología , Leucocitos Mononucleares/inmunología , Masculino , Persona de Mediana Edad , Pruebas de Neutralización , Proteínas Recombinantes/inmunología , Linfocitos T/citología , Linfocitos T/inmunología , Células TH1/inmunología , Células Th2/inmunología , Tuberculina/inmunologíaRESUMEN
To understand the molecular basis of parasite-specific anergy in human lymphatic filariasis caused by the nematode Wuchereria bancrofti, parasite antigen-dependent cellular proliferation and cytokine gene expression were investigated. By reverse transcriptase polymerase chain reaction (RT-PCR), the levels of cytokine mRNA were determined in the peripheral blood mononuclear cells (PBMCs) of different clinical groups of filariasis patients. This includes individuals with circulating microfilariae (MF), patients with chronic lymphatic obstruction (CP), and exposed but uninfected individuals (EN). Those with CP exhibited both a Th2 and a Th1 parasite antigen-driven response. In PBMCs from those with MF, there was a marked downregulation of cellular response to parasite antigens, with lowered expression of Th1-specific cytokines (IFN-gamma and IL-2) and this was paralleled by increased IL-10 expression. The EN individuals had a purely Th1-type pattern with absence of IL-4 and IL-5 expression. Further, the mRNA expression of the costimulatory surface marker, CD80 (B7-1), was not associated with either disease status or IL-10 expression. There was a significant negative correlation between IL-10 mRNA expression and PBMC proliferation in the MF individuals, thus indicating the possible role of IL-10 in antigen-specific hyporesponsiveness.
Asunto(s)
Regulación hacia Abajo , Filariasis Linfática/inmunología , Interleucina-10/genética , Células TH1/inmunología , Wuchereria bancrofti/inmunología , Animales , Antígenos Helmínticos/inmunología , Antígeno B7-1/genética , División Celular , Células Cultivadas , Filariasis Linfática/sangre , Expresión Génica , Humanos , ARN MensajeroRESUMEN
The gas chromatographic detection and quantitative determination of various chlorophenolics as well as resin and fatty acids have been carried out in the chlorination and caustic extraction stage effluents generated in the laboratory by bleaching a bamboo pulp. A number of chlorinated phenols, catechols, guaiacols, syringaldehydes and resin acids as well as non-chlorinated saturated and unsaturated fatty acids together with resin acids have been detected. The concentration of various compounds detected have also been compared with the reported (96)LC(50) values.